Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhi-Rong Zeng

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 25, 2017
Effects of Combination Therapy With Immunomodulators on Trough Levels and Antibodies Against Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease: A Meta-analysisYun Qiu, Ren Mao, Bai-Li Chen, et al.
Journal of Digestive Diseases|January 10, 2020
CYP2C19 polymorphism has no correlation with the efficacy and safety of thalidomide in the treatment of immune-related bowel diseaseRui Feng, Ping Ping Xu, Bai Li Chen, et al.
Gastroenterology Report|August 31, 2022
Visceral adipose volume is correlated with surgical tissue fibrosis in Crohn's disease of the small bowelGang Yuan, Yao He, Qing-Hua Cao, et al.
Therapeutic Advances in Gastroenterology|June 2, 2017
Factors associated with the achievement of mucosal healing in Crohn's disease: the benefit of endoscopic monitoring in treating to targetRen Mao, Yun Qiu, Bai-Li Chen, et al.
Medicine|October 16, 2015
Safety Profile of Thiopurines in Crohn Disease: Analysis of 893 Patient-Years Follow-Up in a Southern China CohortYun Qiu, Ren Mao, Sheng-Hong Zhang, et al.
Zhonghua Nei Ke Za Zhi|August 16, 2013
[The prevalence and characteristics of anemia in Crohn's disease in the Chinese]Rui-han Tang, Kang Chao, Sheng-hong Zhang, et al.
Therapeutic Advances in Gastroenterology|December 17, 2020
Classifying Crohn's disease into colon-involving versus non-colon-involving groups is a better predictor of clinical outcomes than the Montreal classificationSi-Nan Lin, Dan-Ping Zheng, Yun Qiu, et al.
Journal of Gastroenterology and Hepatology|September 4, 2018
Low 6-thioguanine nucleotide level: Effective in maintaining remission in Chinese patients with Crohn's diseaseRui Feng, Jing Guo, Sheng-Hong Zhang, et al.
Stem Cell Research & Therapy|June 7, 2017
Systematic review with meta-analysis: the efficacy and safety of stem cell therapy for Crohn's diseaseYun Qiu, Man-Ying Li, Ting Feng, et al.
Inflammatory Bowel Diseases|May 23, 2018
6-Thioguanine Nucleotide Levels Are Associated With Mucosal Healing in Patients With Crohn's DiseaseRen Mao, Jing Guo, Raphael Luber, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 25, 2017
Effects of Combination Therapy With Immunomodulators on Trough Levels and Antibodies Against Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease: A Meta-analysisYun Qiu, Ren Mao, Bai-Li Chen, et al.
Journal of Digestive Diseases|January 10, 2020
CYP2C19 polymorphism has no correlation with the efficacy and safety of thalidomide in the treatment of immune-related bowel diseaseRui Feng, Ping Ping Xu, Bai Li Chen, et al.
Gastroenterology Report|August 31, 2022
Visceral adipose volume is correlated with surgical tissue fibrosis in Crohn's disease of the small bowelGang Yuan, Yao He, Qing-Hua Cao, et al.
Therapeutic Advances in Gastroenterology|June 2, 2017
Factors associated with the achievement of mucosal healing in Crohn's disease: the benefit of endoscopic monitoring in treating to targetRen Mao, Yun Qiu, Bai-Li Chen, et al.
Medicine|October 16, 2015
Safety Profile of Thiopurines in Crohn Disease: Analysis of 893 Patient-Years Follow-Up in a Southern China CohortYun Qiu, Ren Mao, Sheng-Hong Zhang, et al.
Zhonghua Nei Ke Za Zhi|August 16, 2013
[The prevalence and characteristics of anemia in Crohn's disease in the Chinese]Rui-han Tang, Kang Chao, Sheng-hong Zhang, et al.
Therapeutic Advances in Gastroenterology|December 17, 2020
Classifying Crohn's disease into colon-involving versus non-colon-involving groups is a better predictor of clinical outcomes than the Montreal classificationSi-Nan Lin, Dan-Ping Zheng, Yun Qiu, et al.
Journal of Gastroenterology and Hepatology|September 4, 2018
Low 6-thioguanine nucleotide level: Effective in maintaining remission in Chinese patients with Crohn's diseaseRui Feng, Jing Guo, Sheng-Hong Zhang, et al.
Stem Cell Research & Therapy|June 7, 2017
Systematic review with meta-analysis: the efficacy and safety of stem cell therapy for Crohn's diseaseYun Qiu, Man-Ying Li, Ting Feng, et al.
Inflammatory Bowel Diseases|May 23, 2018
6-Thioguanine Nucleotide Levels Are Associated With Mucosal Healing in Patients With Crohn's DiseaseRen Mao, Jing Guo, Raphael Luber, et al.
Pageof 6